nodes	percent_of_prediction	percent_of_DWPC	metapath
Dyphylline—Diuresis—Vinorelbine—lung cancer	0.0186	0.0576	CcSEcCtD
Dyphylline—Diuresis—Cisplatin—lung cancer	0.0139	0.0431	CcSEcCtD
Dyphylline—Tachypnoea—Gemcitabine—lung cancer	0.0135	0.042	CcSEcCtD
Dyphylline—Inappropriate antidiuretic hormone secretion—Vinblastine—lung cancer	0.0119	0.037	CcSEcCtD
Dyphylline—PDE4A—mammary gland—lung cancer	0.0103	0.145	CbGeAlD
Dyphylline—Inappropriate antidiuretic hormone secretion—Vinorelbine—lung cancer	0.0099	0.0307	CcSEcCtD
Dyphylline—Haematemesis—Erlotinib—lung cancer	0.00957	0.0297	CcSEcCtD
Dyphylline—Caffeine—PIK3CD—lung cancer	0.0095	0.257	CrCbGaD
Dyphylline—Caffeine—PIK3CB—lung cancer	0.0095	0.257	CrCbGaD
Dyphylline—Inappropriate antidiuretic hormone secretion—Cisplatin—lung cancer	0.00741	0.023	CcSEcCtD
Dyphylline—Caffeine—PIK3CA—lung cancer	0.00735	0.199	CrCbGaD
Dyphylline—PDE7B—lung—lung cancer	0.00633	0.0891	CbGeAlD
Dyphylline—Haematuria—Gefitinib—lung cancer	0.00594	0.0184	CcSEcCtD
Dyphylline—Polyuria—Vinorelbine—lung cancer	0.00475	0.0148	CcSEcCtD
Dyphylline—Extrasystoles—Paclitaxel—lung cancer	0.0046	0.0143	CcSEcCtD
Dyphylline—PDE7B—lymph node—lung cancer	0.00433	0.0609	CbGeAlD
Dyphylline—Shock—Crizotinib—lung cancer	0.0043	0.0134	CcSEcCtD
Dyphylline—Flushing—Teniposide—lung cancer	0.00423	0.0131	CcSEcCtD
Dyphylline—PDE4D—lung—lung cancer	0.00411	0.0578	CbGeAlD
Dyphylline—PDE4B—respiratory system—lung cancer	0.00408	0.0574	CbGeAlD
Dyphylline—PDE3A—cardiac atrium—lung cancer	0.00393	0.0553	CbGeAlD
Dyphylline—Shock—Pemetrexed—lung cancer	0.00393	0.0122	CcSEcCtD
Dyphylline—Shock—Gefitinib—lung cancer	0.00391	0.0121	CcSEcCtD
Dyphylline—ADORA1—cardiac atrium—lung cancer	0.00383	0.0539	CbGeAlD
Dyphylline—Hypotension—Gefitinib—lung cancer	0.00371	0.0115	CcSEcCtD
Dyphylline—Agitation—Teniposide—lung cancer	0.00364	0.0113	CcSEcCtD
Dyphylline—PDE4A—lung—lung cancer	0.00364	0.0512	CbGeAlD
Dyphylline—Polyuria—Cisplatin—lung cancer	0.00356	0.0111	CcSEcCtD
Dyphylline—Haematemesis—Methotrexate—lung cancer	0.0034	0.0106	CcSEcCtD
Dyphylline—PDE4B—bronchus—lung cancer	0.00336	0.0473	CbGeAlD
Dyphylline—Polyuria—Paclitaxel—lung cancer	0.0032	0.00993	CcSEcCtD
Dyphylline—Theobromine—CYP2E1—lung cancer	0.00318	0.0861	CrCbGaD
Dyphylline—Tachycardia—Teniposide—lung cancer	0.00316	0.00981	CcSEcCtD
Dyphylline—Hypotension—Teniposide—lung cancer	0.00302	0.00939	CcSEcCtD
Dyphylline—PDE4B—trachea—lung cancer	0.00302	0.0425	CbGeAlD
Dyphylline—PDE3A—lung—lung cancer	0.00301	0.0423	CbGeAlD
Dyphylline—Diarrhoea—Crizotinib—lung cancer	0.00299	0.00929	CcSEcCtD
Dyphylline—Irritability—Cisplatin—lung cancer	0.00298	0.00926	CcSEcCtD
Dyphylline—Haematemesis—Doxorubicin—lung cancer	0.00295	0.00914	CcSEcCtD
Dyphylline—ADORA1—lung—lung cancer	0.00293	0.0412	CbGeAlD
Dyphylline—PDE4B—cardiac atrium—lung cancer	0.00283	0.0399	CbGeAlD
Dyphylline—PDE4D—lymph node—lung cancer	0.00281	0.0395	CbGeAlD
Dyphylline—Vomiting—Crizotinib—lung cancer	0.00278	0.00863	CcSEcCtD
Dyphylline—Ventricular arrhythmia—Doxorubicin—lung cancer	0.00276	0.00858	CcSEcCtD
Dyphylline—Albuminuria—Doxorubicin—lung cancer	0.00274	0.00851	CcSEcCtD
Dyphylline—Diarrhoea—Pemetrexed—lung cancer	0.00273	0.00849	CcSEcCtD
Dyphylline—Diarrhoea—Gefitinib—lung cancer	0.00272	0.00843	CcSEcCtD
Dyphylline—Flushing—Vinorelbine—lung cancer	0.00268	0.00832	CcSEcCtD
Dyphylline—Convulsion—Vinblastine—lung cancer	0.00262	0.00814	CcSEcCtD
Dyphylline—Hyperglycaemia—Gemcitabine—lung cancer	0.00262	0.00812	CcSEcCtD
Dyphylline—Nausea—Crizotinib—lung cancer	0.0026	0.00806	CcSEcCtD
Dyphylline—Abdominal pain upper—Paclitaxel—lung cancer	0.00256	0.00796	CcSEcCtD
Dyphylline—Vomiting—Pemetrexed—lung cancer	0.00254	0.00789	CcSEcCtD
Dyphylline—Vomiting—Gefitinib—lung cancer	0.00252	0.00784	CcSEcCtD
Dyphylline—PDE4A—lymph node—lung cancer	0.00249	0.035	CbGeAlD
Dyphylline—Haematuria—Gemcitabine—lung cancer	0.00246	0.00765	CcSEcCtD
Dyphylline—PDE4B—bone marrow—lung cancer	0.00239	0.0337	CbGeAlD
Dyphylline—Nausea—Pemetrexed—lung cancer	0.00237	0.00737	CcSEcCtD
Dyphylline—Nausea—Gefitinib—lung cancer	0.00236	0.00732	CcSEcCtD
Dyphylline—Shock—Erlotinib—lung cancer	0.00233	0.00725	CcSEcCtD
Dyphylline—Palpitations—Vinorelbine—lung cancer	0.00222	0.0069	CcSEcCtD
Dyphylline—Diarrhoea—Teniposide—lung cancer	0.00221	0.00687	CcSEcCtD
Dyphylline—Flushing—Irinotecan—lung cancer	0.00221	0.00686	CcSEcCtD
Dyphylline—Hyperglycaemia—Paclitaxel—lung cancer	0.00219	0.0068	CcSEcCtD
Dyphylline—Abdominal pain upper—Docetaxel—lung cancer	0.00217	0.00675	CcSEcCtD
Dyphylline—PDE4B—lung—lung cancer	0.00217	0.0305	CbGeAlD
Dyphylline—Insomnia—Erlotinib—lung cancer	0.00215	0.00666	CcSEcCtD
Dyphylline—Haematuria—Paclitaxel—lung cancer	0.00206	0.00641	CcSEcCtD
Dyphylline—Vomiting—Teniposide—lung cancer	0.00206	0.00639	CcSEcCtD
Dyphylline—PDE3A—lymph node—lung cancer	0.00206	0.0289	CbGeAlD
Dyphylline—Headache—Teniposide—lung cancer	0.00203	0.00629	CcSEcCtD
Dyphylline—Flushing—Cisplatin—lung cancer	0.00201	0.00623	CcSEcCtD
Dyphylline—ADORA1—lymph node—lung cancer	0.002	0.0282	CbGeAlD
Dyphylline—Tachycardia—Vinorelbine—lung cancer	0.002	0.00622	CcSEcCtD
Dyphylline—Polyuria—Methotrexate—lung cancer	0.00195	0.00607	CcSEcCtD
Dyphylline—Nausea—Teniposide—lung cancer	0.00192	0.00597	CcSEcCtD
Dyphylline—Hypotension—Vinorelbine—lung cancer	0.00192	0.00595	CcSEcCtD
Dyphylline—Flushing—Etoposide—lung cancer	0.00184	0.00571	CcSEcCtD
Dyphylline—Flushing—Paclitaxel—lung cancer	0.0018	0.0056	CcSEcCtD
Dyphylline—Diarrhoea—Vinblastine—lung cancer	0.00169	0.00524	CcSEcCtD
Dyphylline—Theophylline—CYP2E1—lung cancer	0.00167	0.0451	CrCbGaD
Dyphylline—Shock—Irinotecan—lung cancer	0.00167	0.00517	CcSEcCtD
Dyphylline—Theophylline—CYP1A1—lung cancer	0.00164	0.0445	CrCbGaD
Dyphylline—Diarrhoea—Topotecan—lung cancer	0.00164	0.0051	CcSEcCtD
Dyphylline—Irritability—Methotrexate—lung cancer	0.00164	0.00508	CcSEcCtD
Dyphylline—Caffeine—CYP2E1—lung cancer	0.00164	0.0443	CrCbGaD
Dyphylline—Convulsion—Cisplatin—lung cancer	0.00163	0.00506	CcSEcCtD
Dyphylline—Diarrhoea—Erlotinib—lung cancer	0.00162	0.00504	CcSEcCtD
Dyphylline—Caffeine—CYP1A1—lung cancer	0.00161	0.0437	CrCbGaD
Dyphylline—Hypotension—Irinotecan—lung cancer	0.00158	0.00491	CcSEcCtD
Dyphylline—Vomiting—Vinblastine—lung cancer	0.00157	0.00487	CcSEcCtD
Dyphylline—Agitation—Paclitaxel—lung cancer	0.00155	0.00482	CcSEcCtD
Dyphylline—Headache—Vinblastine—lung cancer	0.00155	0.0048	CcSEcCtD
Dyphylline—Hypotension—Gemcitabine—lung cancer	0.00154	0.00478	CcSEcCtD
Dyphylline—Insomnia—Irinotecan—lung cancer	0.00153	0.00475	CcSEcCtD
Dyphylline—Flushing—Docetaxel—lung cancer	0.00153	0.00474	CcSEcCtD
Dyphylline—Vomiting—Topotecan—lung cancer	0.00153	0.00473	CcSEcCtD
Dyphylline—Vomiting—Erlotinib—lung cancer	0.00151	0.00468	CcSEcCtD
Dyphylline—Headache—Topotecan—lung cancer	0.0015	0.00467	CcSEcCtD
Dyphylline—Tachycardia—Cisplatin—lung cancer	0.0015	0.00466	CcSEcCtD
Dyphylline—Palpitations—Paclitaxel—lung cancer	0.00149	0.00464	CcSEcCtD
Dyphylline—Convulsion—Etoposide—lung cancer	0.00149	0.00464	CcSEcCtD
Dyphylline—Insomnia—Gemcitabine—lung cancer	0.00149	0.00463	CcSEcCtD
Dyphylline—Headache—Erlotinib—lung cancer	0.00149	0.00462	CcSEcCtD
Dyphylline—PDE4B—lymph node—lung cancer	0.00148	0.0209	CbGeAlD
Dyphylline—Nausea—Vinblastine—lung cancer	0.00147	0.00455	CcSEcCtD
Dyphylline—Convulsion—Paclitaxel—lung cancer	0.00147	0.00455	CcSEcCtD
Dyphylline—Hypotension—Cisplatin—lung cancer	0.00144	0.00446	CcSEcCtD
Dyphylline—Nausea—Topotecan—lung cancer	0.00142	0.00442	CcSEcCtD
Dyphylline—Nausea—Erlotinib—lung cancer	0.00141	0.00438	CcSEcCtD
Dyphylline—Diarrhoea—Vinorelbine—lung cancer	0.0014	0.00436	CcSEcCtD
Dyphylline—Tachycardia—Etoposide—lung cancer	0.00137	0.00427	CcSEcCtD
Dyphylline—Shock—Paclitaxel—lung cancer	0.00136	0.00422	CcSEcCtD
Dyphylline—Abdominal pain upper—Doxorubicin—lung cancer	0.00136	0.00421	CcSEcCtD
Dyphylline—Tachycardia—Paclitaxel—lung cancer	0.00135	0.00418	CcSEcCtD
Dyphylline—Hypotension—Etoposide—lung cancer	0.00132	0.00408	CcSEcCtD
Dyphylline—Vomiting—Vinorelbine—lung cancer	0.0013	0.00405	CcSEcCtD
Dyphylline—Hypotension—Paclitaxel—lung cancer	0.00129	0.004	CcSEcCtD
Dyphylline—Headache—Vinorelbine—lung cancer	0.00129	0.00399	CcSEcCtD
Dyphylline—Palpitations—Docetaxel—lung cancer	0.00127	0.00393	CcSEcCtD
Dyphylline—Haematuria—Methotrexate—lung cancer	0.00126	0.00391	CcSEcCtD
Dyphylline—Insomnia—Paclitaxel—lung cancer	0.00125	0.00388	CcSEcCtD
Dyphylline—Convulsion—Docetaxel—lung cancer	0.00124	0.00386	CcSEcCtD
Dyphylline—Nausea—Vinorelbine—lung cancer	0.00122	0.00378	CcSEcCtD
Dyphylline—Hyperglycaemia—Doxorubicin—lung cancer	0.00116	0.0036	CcSEcCtD
Dyphylline—Diarrhoea—Irinotecan—lung cancer	0.00116	0.00359	CcSEcCtD
Dyphylline—Shock—Docetaxel—lung cancer	0.00115	0.00357	CcSEcCtD
Dyphylline—Tachycardia—Docetaxel—lung cancer	0.00114	0.00354	CcSEcCtD
Dyphylline—Diarrhoea—Gemcitabine—lung cancer	0.00113	0.0035	CcSEcCtD
Dyphylline—Hypotension—Docetaxel—lung cancer	0.00109	0.00339	CcSEcCtD
Dyphylline—Haematuria—Doxorubicin—lung cancer	0.00109	0.00339	CcSEcCtD
Dyphylline—Vomiting—Irinotecan—lung cancer	0.00108	0.00334	CcSEcCtD
Dyphylline—Headache—Irinotecan—lung cancer	0.00106	0.00329	CcSEcCtD
Dyphylline—Insomnia—Docetaxel—lung cancer	0.00106	0.00328	CcSEcCtD
Dyphylline—Diarrhoea—Cisplatin—lung cancer	0.00105	0.00326	CcSEcCtD
Dyphylline—Vomiting—Gemcitabine—lung cancer	0.00105	0.00325	CcSEcCtD
Dyphylline—Headache—Gemcitabine—lung cancer	0.00103	0.00321	CcSEcCtD
Dyphylline—Nausea—Irinotecan—lung cancer	0.00101	0.00312	CcSEcCtD
Dyphylline—Nausea—Gemcitabine—lung cancer	0.000979	0.00304	CcSEcCtD
Dyphylline—Vomiting—Cisplatin—lung cancer	0.000977	0.00303	CcSEcCtD
Dyphylline—Diarrhoea—Etoposide—lung cancer	0.000963	0.00299	CcSEcCtD
Dyphylline—Flushing—Doxorubicin—lung cancer	0.000954	0.00296	CcSEcCtD
Dyphylline—Diarrhoea—Paclitaxel—lung cancer	0.000944	0.00293	CcSEcCtD
Dyphylline—Nausea—Cisplatin—lung cancer	0.000913	0.00283	CcSEcCtD
Dyphylline—Convulsion—Methotrexate—lung cancer	0.000895	0.00278	CcSEcCtD
Dyphylline—Vomiting—Etoposide—lung cancer	0.000895	0.00278	CcSEcCtD
Dyphylline—Headache—Etoposide—lung cancer	0.000882	0.00274	CcSEcCtD
Dyphylline—Vomiting—Paclitaxel—lung cancer	0.000878	0.00272	CcSEcCtD
Dyphylline—Headache—Paclitaxel—lung cancer	0.000865	0.00268	CcSEcCtD
Dyphylline—Caffeine—ABCB1—lung cancer	0.000858	0.0232	CrCbGaD
Dyphylline—Nausea—Etoposide—lung cancer	0.000836	0.0026	CcSEcCtD
Dyphylline—Agitation—Doxorubicin—lung cancer	0.000822	0.00255	CcSEcCtD
Dyphylline—Nausea—Paclitaxel—lung cancer	0.00082	0.00255	CcSEcCtD
Dyphylline—Diarrhoea—Docetaxel—lung cancer	0.0008	0.00248	CcSEcCtD
Dyphylline—Palpitations—Doxorubicin—lung cancer	0.000791	0.00245	CcSEcCtD
Dyphylline—Hypotension—Methotrexate—lung cancer	0.000788	0.00245	CcSEcCtD
Dyphylline—Convulsion—Doxorubicin—lung cancer	0.000775	0.00241	CcSEcCtD
Dyphylline—Insomnia—Methotrexate—lung cancer	0.000763	0.00237	CcSEcCtD
Dyphylline—Vomiting—Docetaxel—lung cancer	0.000744	0.00231	CcSEcCtD
Dyphylline—Headache—Docetaxel—lung cancer	0.000733	0.00228	CcSEcCtD
Dyphylline—Shock—Doxorubicin—lung cancer	0.000718	0.00223	CcSEcCtD
Dyphylline—Tachycardia—Doxorubicin—lung cancer	0.000713	0.00221	CcSEcCtD
Dyphylline—Nausea—Docetaxel—lung cancer	0.000695	0.00216	CcSEcCtD
Dyphylline—Hypotension—Doxorubicin—lung cancer	0.000682	0.00212	CcSEcCtD
Dyphylline—Insomnia—Doxorubicin—lung cancer	0.00066	0.00205	CcSEcCtD
Dyphylline—Diarrhoea—Methotrexate—lung cancer	0.000577	0.00179	CcSEcCtD
Dyphylline—Vomiting—Methotrexate—lung cancer	0.000536	0.00166	CcSEcCtD
Dyphylline—Headache—Methotrexate—lung cancer	0.000528	0.00164	CcSEcCtD
Dyphylline—Nausea—Methotrexate—lung cancer	0.000501	0.00155	CcSEcCtD
Dyphylline—Diarrhoea—Doxorubicin—lung cancer	0.0005	0.00155	CcSEcCtD
Dyphylline—Vomiting—Doxorubicin—lung cancer	0.000464	0.00144	CcSEcCtD
Dyphylline—Headache—Doxorubicin—lung cancer	0.000457	0.00142	CcSEcCtD
Dyphylline—Nausea—Doxorubicin—lung cancer	0.000434	0.00135	CcSEcCtD
Dyphylline—PDE4C—Signaling Pathways—IL2—lung cancer	7.49e-05	0.000131	CbGpPWpGaD
Dyphylline—PDE3A—GPCR downstream signaling—PIK3CA—lung cancer	7.47e-05	0.000131	CbGpPWpGaD
Dyphylline—PDE4C—Signaling by GPCR—IL6—lung cancer	7.45e-05	0.000131	CbGpPWpGaD
Dyphylline—PDE4B—Signaling by GPCR—EGFR—lung cancer	7.43e-05	0.00013	CbGpPWpGaD
Dyphylline—PDE3A—Signaling by GPCR—KRAS—lung cancer	7.38e-05	0.00013	CbGpPWpGaD
Dyphylline—PDE7A—Signaling Pathways—TP53—lung cancer	7.38e-05	0.000129	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—FGFR1—lung cancer	7.35e-05	0.000129	CbGpPWpGaD
Dyphylline—PDE4D—Signaling by GPCR—PIK3CA—lung cancer	7.32e-05	0.000129	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—MAP2K1—lung cancer	7.31e-05	0.000128	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—CCND1—lung cancer	7.3e-05	0.000128	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—MDM2—lung cancer	7.3e-05	0.000128	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—JUN—lung cancer	7.28e-05	0.000128	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—RAF1—lung cancer	7.27e-05	0.000128	CbGpPWpGaD
Dyphylline—PDE7B—Signaling Pathways—IL6—lung cancer	7.26e-05	0.000127	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—PIK3CD—lung cancer	7.26e-05	0.000127	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—HIF1A—lung cancer	7.24e-05	0.000127	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—MAP2K1—lung cancer	7.22e-05	0.000127	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—ERBB2—lung cancer	7.19e-05	0.000126	CbGpPWpGaD
Dyphylline—ADORA1—GPCR downstream signaling—PIK3CA—lung cancer	7.19e-05	0.000126	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—PIK3CD—lung cancer	7.17e-05	0.000126	CbGpPWpGaD
Dyphylline—ADORA1—Signaling by GPCR—KRAS—lung cancer	7.11e-05	0.000125	CbGpPWpGaD
Dyphylline—PDE4B—GPCR downstream signaling—PIK3CA—lung cancer	7.1e-05	0.000125	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—PIK3CB—lung cancer	7.1e-05	0.000125	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—MTOR—lung cancer	7.1e-05	0.000125	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—MMP9—lung cancer	7.09e-05	0.000124	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—CDKN1A—lung cancer	7.06e-05	0.000124	CbGpPWpGaD
Dyphylline—PDE7A—Signaling Pathways—HRAS—lung cancer	7.06e-05	0.000124	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—PTEN—lung cancer	7.05e-05	0.000124	CbGpPWpGaD
Dyphylline—PDE4B—Signaling by GPCR—KRAS—lung cancer	7.02e-05	0.000123	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—APOA1—lung cancer	6.98e-05	0.000123	CbGpPWpGaD
Dyphylline—PDE4A—Signaling by GPCR—PIK3CA—lung cancer	6.97e-05	0.000122	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—MDM2—lung cancer	6.94e-05	0.000122	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—RAF1—lung cancer	6.92e-05	0.000121	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—KDR—lung cancer	6.92e-05	0.000121	CbGpPWpGaD
Dyphylline—PDE4C—Signaling by GPCR—AKT1—lung cancer	6.87e-05	0.000121	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—ERBB2—lung cancer	6.85e-05	0.00012	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—CXCL8—lung cancer	6.82e-05	0.00012	CbGpPWpGaD
Dyphylline—PDE3A—Signaling by GPCR—PIK3CA—lung cancer	6.78e-05	0.000119	CbGpPWpGaD
Dyphylline—PDE4D—Signaling by GPCR—HRAS—lung cancer	6.78e-05	0.000119	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—PIK3CB—lung cancer	6.76e-05	0.000119	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—MTOR—lung cancer	6.76e-05	0.000119	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—MDM2—lung cancer	6.75e-05	0.000119	CbGpPWpGaD
Dyphylline—PDE7A—Signaling Pathways—IL6—lung cancer	6.75e-05	0.000119	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—RAF1—lung cancer	6.73e-05	0.000118	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—EP300—lung cancer	6.72e-05	0.000118	CbGpPWpGaD
Dyphylline—PDE7B—Signaling Pathways—AKT1—lung cancer	6.7e-05	0.000118	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—ERBB2—lung cancer	6.66e-05	0.000117	CbGpPWpGaD
Dyphylline—PDE4D—GPCR downstream signaling—AKT1—lung cancer	6.59e-05	0.000116	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—PIK3CB—lung cancer	6.57e-05	0.000115	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—MTOR—lung cancer	6.57e-05	0.000115	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—SRC—lung cancer	6.53e-05	0.000115	CbGpPWpGaD
Dyphylline—ADORA1—Signaling by GPCR—PIK3CA—lung cancer	6.53e-05	0.000115	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—CASP3—lung cancer	6.53e-05	0.000115	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—IL2—lung cancer	6.52e-05	0.000114	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—MDM2—lung cancer	6.5e-05	0.000114	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—CXCL8—lung cancer	6.49e-05	0.000114	CbGpPWpGaD
Dyphylline—PDE4D—Signaling by GPCR—IL6—lung cancer	6.49e-05	0.000114	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—RAF1—lung cancer	6.48e-05	0.000114	CbGpPWpGaD
Dyphylline—PDE4B—Signaling by GPCR—PIK3CA—lung cancer	6.45e-05	0.000113	CbGpPWpGaD
Dyphylline—PDE4A—Signaling by GPCR—HRAS—lung cancer	6.45e-05	0.000113	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—MDM2—lung cancer	6.43e-05	0.000113	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—ERBB2—lung cancer	6.41e-05	0.000112	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—RAF1—lung cancer	6.4e-05	0.000112	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—APC—lung cancer	6.37e-05	0.000112	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—KIT—lung cancer	6.37e-05	0.000112	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—PIK3CG—lung cancer	6.37e-05	0.000112	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling by GPCR—NRAS—lung cancer	6.37e-05	0.000112	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—VEGFA—lung cancer	6.36e-05	0.000112	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—CCND1—lung cancer	6.35e-05	0.000112	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—JUN—lung cancer	6.34e-05	0.000111	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—ERBB2—lung cancer	6.33e-05	0.000111	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—MTOR—lung cancer	6.33e-05	0.000111	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—PIK3CB—lung cancer	6.33e-05	0.000111	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—CXCL8—lung cancer	6.32e-05	0.000111	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—STAT3—lung cancer	6.3e-05	0.000111	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—EGF—lung cancer	6.3e-05	0.000111	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—NRAS—lung cancer	6.29e-05	0.00011	CbGpPWpGaD
Dyphylline—PDE3A—Signaling by GPCR—HRAS—lung cancer	6.27e-05	0.00011	CbGpPWpGaD
Dyphylline—PDE4A—GPCR downstream signaling—AKT1—lung cancer	6.27e-05	0.00011	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—MTOR—lung cancer	6.25e-05	0.00011	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—PIK3CB—lung cancer	6.25e-05	0.00011	CbGpPWpGaD
Dyphylline—PDE7A—Signaling Pathways—AKT1—lung cancer	6.23e-05	0.000109	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—CASP3—lung cancer	6.21e-05	0.000109	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—IL2—lung cancer	6.2e-05	0.000109	CbGpPWpGaD
Dyphylline—PDE4A—Signaling by GPCR—IL6—lung cancer	6.17e-05	0.000108	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—MMP9—lung cancer	6.17e-05	0.000108	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—CDKN1A—lung cancer	6.15e-05	0.000108	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—PTEN—lung cancer	6.13e-05	0.000108	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling by GPCR—MAPK3—lung cancer	6.1e-05	0.000107	CbGpPWpGaD
Dyphylline—PDE3A—GPCR downstream signaling—AKT1—lung cancer	6.1e-05	0.000107	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—CXCL8—lung cancer	6.08e-05	0.000107	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—POMC—lung cancer	6.07e-05	0.000106	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—CCND1—lung cancer	6.05e-05	0.000106	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—CASP3—lung cancer	6.04e-05	0.000106	CbGpPWpGaD
Dyphylline—ADORA1—Signaling by GPCR—HRAS—lung cancer	6.04e-05	0.000106	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—IL2—lung cancer	6.04e-05	0.000106	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—JUN—lung cancer	6.04e-05	0.000106	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—MAPK3—lung cancer	6.02e-05	0.000106	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—CXCL8—lung cancer	6.01e-05	0.000105	CbGpPWpGaD
Dyphylline—PDE3A—Signaling by GPCR—IL6—lung cancer	6.01e-05	0.000105	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—BRAF—lung cancer	5.99e-05	0.000105	CbGpPWpGaD
Dyphylline—PDE4D—Signaling by GPCR—AKT1—lung cancer	5.98e-05	0.000105	CbGpPWpGaD
Dyphylline—PDE4B—Signaling by GPCR—HRAS—lung cancer	5.97e-05	0.000105	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—IL6R—lung cancer	5.92e-05	0.000104	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—CREBBP—lung cancer	5.91e-05	0.000104	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—CCND1—lung cancer	5.88e-05	0.000103	CbGpPWpGaD
Dyphylline—ADORA1—GPCR downstream signaling—AKT1—lung cancer	5.87e-05	0.000103	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—MMP9—lung cancer	5.87e-05	0.000103	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—JUN—lung cancer	5.87e-05	0.000103	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—MYC—lung cancer	5.86e-05	0.000103	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—CDKN1A—lung cancer	5.85e-05	0.000103	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—EP300—lung cancer	5.85e-05	0.000103	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—PTEN—lung cancer	5.84e-05	0.000102	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—CASP3—lung cancer	5.82e-05	0.000102	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—IL2—lung cancer	5.81e-05	0.000102	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling by GPCR—EGFR—lung cancer	5.81e-05	0.000102	CbGpPWpGaD
Dyphylline—PDE4B—GPCR downstream signaling—AKT1—lung cancer	5.8e-05	0.000102	CbGpPWpGaD
Dyphylline—ADORA1—Signaling by GPCR—IL6—lung cancer	5.78e-05	0.000101	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—CASP3—lung cancer	5.75e-05	0.000101	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—IL2—lung cancer	5.74e-05	0.000101	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—EGFR—lung cancer	5.73e-05	0.0001	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—MMP9—lung cancer	5.71e-05	0.0001	CbGpPWpGaD
Dyphylline—PDE4B—Signaling by GPCR—IL6—lung cancer	5.71e-05	0.0001	CbGpPWpGaD
Dyphylline—PDE4A—Signaling by GPCR—AKT1—lung cancer	5.7e-05	9.99e-05	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—CDKN1A—lung cancer	5.69e-05	9.99e-05	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—SRC—lung cancer	5.69e-05	9.98e-05	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—PTEN—lung cancer	5.68e-05	9.97e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—CCND1—lung cancer	5.66e-05	9.94e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—JUN—lung cancer	5.65e-05	9.92e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—MAP2K1—lung cancer	5.64e-05	9.9e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—PIK3CD—lung cancer	5.6e-05	9.83e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—CCND1—lung cancer	5.6e-05	9.82e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—JUN—lung cancer	5.58e-05	9.8e-05	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—EP300—lung cancer	5.57e-05	9.77e-05	CbGpPWpGaD
Dyphylline—ADORA2A—GPCR downstream signaling—PIK3CA—lung cancer	5.55e-05	9.74e-05	CbGpPWpGaD
Dyphylline—PDE3A—Signaling by GPCR—AKT1—lung cancer	5.54e-05	9.72e-05	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—VEGFA—lung cancer	5.54e-05	9.72e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—MMP9—lung cancer	5.5e-05	9.65e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling by GPCR—KRAS—lung cancer	5.49e-05	9.63e-05	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—STAT3—lung cancer	5.49e-05	9.63e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—CDKN1A—lung cancer	5.48e-05	9.62e-05	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—NRAS—lung cancer	5.47e-05	9.6e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—PTEN—lung cancer	5.47e-05	9.59e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—MMP9—lung cancer	5.43e-05	9.54e-05	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—EP300—lung cancer	5.42e-05	9.5e-05	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—SRC—lung cancer	5.41e-05	9.5e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—CDKN1A—lung cancer	5.41e-05	9.5e-05	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—KRAS—lung cancer	5.41e-05	9.49e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—PTEN—lung cancer	5.4e-05	9.48e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling by GPCR—AKT1—lung cancer	5.33e-05	9.36e-05	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—VEGFA—lung cancer	5.27e-05	9.25e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling by GPCR—AKT1—lung cancer	5.27e-05	9.25e-05	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—SRC—lung cancer	5.27e-05	9.24e-05	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—MAPK3—lung cancer	5.24e-05	9.2e-05	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—STAT3—lung cancer	5.22e-05	9.16e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—EP300—lung cancer	5.21e-05	9.15e-05	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—NRAS—lung cancer	5.21e-05	9.14e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—EP300—lung cancer	5.15e-05	9.04e-05	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—VEGFA—lung cancer	5.13e-05	9e-05	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—MYC—lung cancer	5.1e-05	8.94e-05	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—STAT3—lung cancer	5.08e-05	8.91e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—SRC—lung cancer	5.07e-05	8.9e-05	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—NRAS—lung cancer	5.07e-05	8.89e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling by GPCR—PIK3CA—lung cancer	5.04e-05	8.85e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—MDM2—lung cancer	5.02e-05	8.81e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—SRC—lung cancer	5.01e-05	8.79e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—RAF1—lung cancer	5e-05	8.78e-05	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—MAPK3—lung cancer	4.99e-05	8.75e-05	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—EGFR—lung cancer	4.99e-05	8.75e-05	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—PIK3CA—lung cancer	4.97e-05	8.72e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—ERBB2—lung cancer	4.95e-05	8.69e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—VEGFA—lung cancer	4.94e-05	8.66e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—STAT3—lung cancer	4.89e-05	8.58e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—MTOR—lung cancer	4.88e-05	8.57e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—PIK3CB—lung cancer	4.88e-05	8.57e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—VEGFA—lung cancer	4.88e-05	8.56e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—NRAS—lung cancer	4.88e-05	8.56e-05	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—MAPK3—lung cancer	4.85e-05	8.52e-05	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—MYC—lung cancer	4.85e-05	8.51e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—STAT3—lung cancer	4.83e-05	8.48e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—NRAS—lung cancer	4.82e-05	8.46e-05	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—TP53—lung cancer	4.81e-05	8.44e-05	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—EGFR—lung cancer	4.75e-05	8.33e-05	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—MYC—lung cancer	4.72e-05	8.28e-05	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—KRAS—lung cancer	4.71e-05	8.26e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—CXCL8—lung cancer	4.69e-05	8.24e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—MAPK3—lung cancer	4.67e-05	8.2e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling by GPCR—HRAS—lung cancer	4.66e-05	8.18e-05	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—EGFR—lung cancer	4.62e-05	8.1e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—MAPK3—lung cancer	4.62e-05	8.1e-05	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—HRAS—lung cancer	4.6e-05	8.07e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—MYC—lung cancer	4.54e-05	7.97e-05	CbGpPWpGaD
Dyphylline—ADORA2A—GPCR downstream signaling—AKT1—lung cancer	4.53e-05	7.96e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—CASP3—lung cancer	4.49e-05	7.88e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—MYC—lung cancer	4.49e-05	7.88e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—IL2—lung cancer	4.49e-05	7.87e-05	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—KRAS—lung cancer	4.48e-05	7.87e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling by GPCR—IL6—lung cancer	4.46e-05	7.83e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—EGFR—lung cancer	4.44e-05	7.8e-05	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—IL6—lung cancer	4.4e-05	7.72e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—EGFR—lung cancer	4.39e-05	7.71e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—CCND1—lung cancer	4.37e-05	7.67e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—JUN—lung cancer	4.36e-05	7.66e-05	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—KRAS—lung cancer	4.36e-05	7.65e-05	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—PIK3CA—lung cancer	4.33e-05	7.59e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—MMP9—lung cancer	4.25e-05	7.45e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—CDKN1A—lung cancer	4.23e-05	7.42e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—PTEN—lung cancer	4.22e-05	7.41e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—KRAS—lung cancer	4.2e-05	7.37e-05	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—TP53—lung cancer	4.19e-05	7.35e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—KRAS—lung cancer	4.15e-05	7.28e-05	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—PIK3CA—lung cancer	4.12e-05	7.23e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling by GPCR—AKT1—lung cancer	4.12e-05	7.23e-05	CbGpPWpGaD
Dyphylline—PDE4C—Signaling Pathways—AKT1—lung cancer	4.06e-05	7.13e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—EP300—lung cancer	4.03e-05	7.06e-05	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—PIK3CA—lung cancer	4.01e-05	7.03e-05	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—HRAS—lung cancer	4e-05	7.03e-05	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—TP53—lung cancer	3.98e-05	6.99e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—SRC—lung cancer	3.91e-05	6.87e-05	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—TP53—lung cancer	3.88e-05	6.8e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—PIK3CA—lung cancer	3.86e-05	6.77e-05	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—IL6—lung cancer	3.83e-05	6.72e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—VEGFA—lung cancer	3.81e-05	6.69e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—PIK3CA—lung cancer	3.81e-05	6.69e-05	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—HRAS—lung cancer	3.81e-05	6.69e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—STAT3—lung cancer	3.77e-05	6.62e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—NRAS—lung cancer	3.77e-05	6.61e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—TP53—lung cancer	3.73e-05	6.55e-05	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—HRAS—lung cancer	3.71e-05	6.5e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—TP53—lung cancer	3.69e-05	6.47e-05	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—IL6—lung cancer	3.65e-05	6.4e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—MAPK3—lung cancer	3.61e-05	6.33e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—HRAS—lung cancer	3.57e-05	6.26e-05	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—IL6—lung cancer	3.55e-05	6.23e-05	CbGpPWpGaD
Dyphylline—PDE4D—Signaling Pathways—AKT1—lung cancer	3.53e-05	6.2e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—HRAS—lung cancer	3.53e-05	6.19e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—MYC—lung cancer	3.51e-05	6.16e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—EGFR—lung cancer	3.43e-05	6.02e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—IL6—lung cancer	3.41e-05	5.99e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—IL6—lung cancer	3.37e-05	5.92e-05	CbGpPWpGaD
Dyphylline—PDE4A—Signaling Pathways—AKT1—lung cancer	3.36e-05	5.9e-05	CbGpPWpGaD
Dyphylline—PDE3A—Signaling Pathways—AKT1—lung cancer	3.27e-05	5.74e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—KRAS—lung cancer	3.24e-05	5.69e-05	CbGpPWpGaD
Dyphylline—ADORA1—Signaling Pathways—AKT1—lung cancer	3.15e-05	5.53e-05	CbGpPWpGaD
Dyphylline—PDE4B—Signaling Pathways—AKT1—lung cancer	3.11e-05	5.46e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—PIK3CA—lung cancer	2.98e-05	5.23e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—TP53—lung cancer	2.88e-05	5.05e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—HRAS—lung cancer	2.75e-05	4.83e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—IL6—lung cancer	2.64e-05	4.63e-05	CbGpPWpGaD
Dyphylline—ADORA2A—Signaling Pathways—AKT1—lung cancer	2.43e-05	4.27e-05	CbGpPWpGaD
